Hypolipidemic effect of a new aryloxy compound, S-8527, in experimental animals.
D000818:Animals; D002264:Carboxylic Acids / Q000627:therapeutic use; D002784:Cholesterol / Q000097:blood; D002994:Clofibrate / Q000627:therapeutic use; D003510:Cyclohexanes / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D005990:Glycerol; D006949:Hyperlipidemias / Q000139:chemically induced / Q000188:drug therapy*; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D008099:Liver / Q000187:drug effects / Q000378:metabolism; D008297:Male; D051379:Mice; D010647:Phenyl Ethers / Q000627:therapeutic use*; D011092:Polyethylene Glycols; D011817:Rabbits; D051381:Rats; D013045:Species Specificity; D013997:Time Factors; D014280:Triglycerides / Q000097:blood / Q000378:metabolism
D002264:Carboxylic Acids; D003510:Cyclohexanes; D000960:Hypolipidemic Agents; D010647:Phenyl Ethers; D014280:Triglycerides; D011092:Polyethylene Glycols; D002784:Cholesterol; D002994:Clofibrate; D005990:Glycerol